LevitasBio strengthens executive leadership team, tapping seasoned commercial and finance veterans from biotech industry

MENLO PARK, CA LevitasBio, biotech leader in label-free sample enrichment for cellular analysis, today announced the expansion of its leadership team with the appointment of two senior leaders from the biotech industry to lead commercial strategy and finance.  Paul Steinberg, a veteran commercial and strategic leader in life sciences tools, has been appointed Chief Commercial […]

LevitasBio secures $18 million in Series B funding led by Thalys Medical

MENLO PARK, CA LevitasBio, a life science tools leader in label-free sample enrichment for cellular analysis, today announced the closing of its $18 million Series B financing round, led by Thalys Medical and joined by Series A lead investor Decheng Capital.   The company is the manufacturer of the LeviCell – the world’s first label-free […]

Stanford Spinout LevitasBio to Launch Magnetic Levitation Cell Separation Platform

Excerpt from the article published by Genomeweb here. NEW YORK – LevitasBio, a Stanford University spinout, is preparing the launch of a technology that sounds nearly imaginary: magnetic levitation-based cell separation.”Unlike anything else out there, when it comes to separating particles, we don’t attach or bind anything to the cells,” said CEO Martin Pieprzyk. “No […]

Levitating Cells to Sort the Fit and the Fat

Density is a core material property and varies between different cell types, mainly based on differences in their lipid content. Sorting based on density enables various biomedical applications such as multi‐omics in precision medicine and regenerative repair in medicine. However, a significant challenge is sorting cells of the same type based on density differences. Here, […]